Scott Allison, president, Life Sciences & Healthcare Sector, DHL, gives us a rundown of the connected warehouse and how innovations in logistics are benefitting this rapidly changing world.
Independent consulting group, NDA, has announced its findings from its fifth annual comparison of drug approvals in Europe and the US in preparation for this year’s DIA Europe in Basel, Switzerland.
As pharma encounters massive shifts in public perception, which is seemingly negative in the current climate, Nick Johns from ConsumerSafety.org, looks at the focus of pharma in the US and how shifting this could benefit public perception
The BIA and business intelligence group, Informa, have released their first quarterly financing update on the biotech sector, showing that venture capital financing and follow on financings on the public markets are off to a solid start
Here, Dr Neil Polwart, Novarum founder and BBI group head of mobile, goes into greater detail about how digital technologies will herald a new era for pharma.
With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders
According to data and analytics company, GlobalData, pharmaceutical sales within the age-related macular degeneration (AMD) markets will soar to $11.5 billion by the year 2026.
Here, we talk with David Davies, whose appointment as the new head of development at Medherant marks the company’s move into clinical development of the ibuprofen TEPI Patch.
According to the latest figures from the annual Labour Turnover survey, from the manufacturers’ organisation, EEF, the number of people leaving companies rose from 12.3% in 2016 to 13.2% in 2017, although the rate still sits below that of 2015
The industry’s largest survey on serialisation readiness, including data from 660 respondents in the pharma supply chain, has been published by TraceLink.
